Raw count matrix for 418 baseline samples
Count matrix from 418 pre-treatment (Ven-Obi or Clb-Obi) CD19+ B cells
- 29/09/2022
- 1 sample
- DAC: EGAC00001002874
DUO:0000015 version: 2021-02-23
no general methods research
This data use modifier indicates that use does not allow methods development research (e.g., development of software or algorithms).
DUO:0000025 version: 2021-02-23
time limit on use
This data use modifier indicates that use is approved for a specific number of months.
DUO:0000026 version: 2021-02-23
user specific restriction
This data use modifier indicates that use is limited to use by approved users.
DUO:0000027 version: 2021-02-23
project specific restriction
This data use modifier indicates that use is limited to use within an approved project.
DUO:0000028 version: 2021-02-23
institution specific restriction
This data use modifier indicates that use is limited to use within an approved institution.
Genentech Data Access Agreement for Academic Institutions
Please submit an access request and the DAC will review the request and provide additional instructions.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001006596 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Quality Report |
Located in
i
|
|---|---|---|---|---|
| EGAF00007237034 | csv | 34.3 MB |
|
|
| 1 File (34.3 MB) | ||||
